10x Genomics, a leader in single-cell and spatial biology, announced its Q3 2024 financial results, revealing a slight revenue decline attributed to sales restructuring and cautious customer spending. Despite the challenges, the company remains optimistic about future growth, driven by its new product launches and the expanding market for its innovative technologies.
10x Genomics, a leader in single-cell and spatial biology, announced its Q3 2024 financial results, revealing a slight revenue decline attributed to sales restructuring and cautious customer spending. Despite the challenges, the company remains optimistic about future growth, driven by its new product launches and the expanding market for its innovative technologies.
